Anti-CD45 抗体 [EP322Y]
Anti-CD45 antibody [EP322Y]
- 20ul selling size
- RabMAb
- Recombinant
- 詳細を見る
5
(14 Reviews)
|
(110 Publications)
Anti-CD45 antibody [EP322Y] (ab40763) is a rabbit monoclonal antibody detecting CD45 in Western Blot, Flow Cytometry (Intra), IHC-P, ICC/IF. Suitable for Human.
- Biophysical QC for unrivalled batch-batch consistency
- Over 50 publications
- Trusted since 2006
別名を表示する
CD45, PTPRC, Receptor-type tyrosine-protein phosphatase C, Leukocyte common antigen, T200, L-CA
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-CD45 antibody [EP322Y] (AB40763)
Overlay histogram showing Jurkat (Human T cell leukemia cell line from peripheral blood) cells fixed in 4% PFA and stained with purified ab40763 at a dilution of 1 in 20 (red line).
The secondary antibody used was FITC goat anti-rabbit at a dilution of 1 in 500. Rabbit monoclonal IgG was used as an isotype control (black line) and cells incubated in the absence of both primary and secondary antibody were used as a negative control (blue line).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)
Unpurified ab40763 showing positive staining in normal colon lymphoid cells tissue.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)
Unpurified ab40763 showing positive staining in normal spleen tissue.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CD45 antibody [EP322Y] (AB40763)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized Jurkat cells labelling CD45 with ab40763 at 1/100 (6.1 ug/ml) dilution, followed by ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) antibody at 1/1000 2ug/ml dilution (Green). Confocal image showing membranouse staining in Jurkat cells and no staining in 293T cells. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) at 1000 2ug/ml dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-CD45 antibody [EP322Y] (AB40763)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized 293T (Human embryonic kidney epithelial cell, Left) / Jurkat (Human T cell leukemia T lymphocyte, Right) cells labelling CD45 with ab40763 at 1/500 dilution (0.1ug)/ Right compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody. Negative control : 293T. (PMID : 16005866)
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)
Immunohistochemical staining of paraffin embedded human tonsil with purified ab40763 at a working dilution of 1/250.
The secondary antibody used is HRP goat anti-rabbit IgG H&L (ab97051) at 1/500. The sample is counterstained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0.
PBS was used instead of the primary antibody as the negative control (shown in the inset).
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-CD45 antibody [EP322Y] (AB40763)
Flow cytometry staining of human peripheral blood mononuclear cells (PBMCs) with ab40763 (right) or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (left).
PBMCs were incubated for 30 min on ice in 1x PBS containing 10 µg/ml human IgG and 10 % normal goat serum to block FC receptors and non-specific protein-protein interactions. Cells were fixed and permeabilised with BD Cytofix/Cytoperm™ for 20 min, followed by the addition of antibody ab40763 or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (1x 106 in 100 µl at 0.2 μg/ml (1/10,500)) for 30 min at 22°C.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min at 22°C.
Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter. Events were gated on live cells.
- WB
Lab
Western blot - Anti-CD45 antibody [EP322Y] (AB40763)
This blot was produced using a 3-8% Tris Acetate gel under the TA buffer system. The gel was run at 150V for 60 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes.
The membrane was then blocked for an hour using 3% milk before being incubated with ab40763 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution ab133406.
All lanes:
Western blot - Anti-CD45 antibody [EP322Y] (ab40763) at 1/5000 dilution
All lanes:
Jurkat (Human T cell lymphoblast-like cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 147 kDa
Observed band size: 200 kDa
true
Exposure time: 8min
- WB
Lab
Western blot - Anti-CD45 antibody [EP322Y] (AB40763)
Blocking/Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-CD45 antibody [EP322Y] (ab40763) at 1/5000 dilution
All lanes:
Raji (Human Burkitt's lymphoma cell line) cell lysate at 20 µg
Secondary
All lanes:
HRP goat anti-rabbit IgG (H+L) at 1/50000 dilution
Predicted band size: 147 kDa
Observed band size: 200 kDa
false
- WB
Lab
Western blot - Anti-CD45 antibody [EP322Y] (AB40763)
False colour image of Western blot : Anti-CD45 antibody [EP322Y] staining at 1/5000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab40763 was shown to bind specifically to CD45. A band was observed at 160-220 kDa in wild-type Jurkat cell lysates with no signal observed at this size in PTPRC CRISPR-Cas9 edited cell line ab274932 (CRISPR-Cas9 edited cell lysate ab274990). The band observed in the CRISPR-Cas9 edited lysate lane below 160-220 kDa is likely to represent a truncated form of CD45. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and PTPRC CRISPR-Cas9 edited Jurkat cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-CD45 antibody [EP322Y] (ab40763) at 1/5000 dilution
Lane 1:
Wild-type Jurkat cell lysate at 20 µg
Lane 2:
PTPRC CRISPR-Cas9 edited Jurkat cell lysate at 20 µg
Lane 3:
THP-1 cell lysate at 20 µg
Lane 4:
MCF7 cell lysate at 20 µg
Predicted band size: 147 kDa
Observed band size: 160-220 kDa
false
- WB
Lab
Western blot - Anti-CD45 antibody [EP322Y] (AB40763)
False colour image of Western blot : Anti-CD45 antibody [EP322Y] staining at 1/5000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab40763 was shown to bind specifically to CD45. A band was observed at 160-220 kDa in wild-type Jurkat cell lysates with no signal observed at this size in PTPRC knockout cell line ab274932 (knockout cell lysate ab274990). The band observed in the knockout lysate lane below 160-220 kDa is likely to represent a truncated form of CD45. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and PTPRC knockout Jurkat cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-CD45 antibody [EP322Y] (ab40763) at 1/5000 dilution
Lane 1:
Wild-type Jurkat cell lysate at 20 µg
Lane 2:
PTPRC knockout Jurkat cell lysate at 20 µg
Lane 3:
THP-1 cell lysate at 20 µg
Lane 4:
MCF7 cell lysate at 20 µg
false
- WB
Lab
Western blot - Anti-CD45 antibody [EP322Y] (AB40763)
Blocking/Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-CD45 antibody [EP322Y] (ab40763) at 1/5000 dilution
All lanes:
HuT-78 cell lysate at 20 µg
Secondary
All lanes:
HRP goat anti-rabbit IgG (H+L) at 1/50000 dilution
Predicted band size: 147 kDa
Observed band size: 200 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)
Unpurified ab40763 showing negative staining in skeletal muscle tissue.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD45 antibody [EP322Y] (AB40763)
Unpurified ab40763 showing negative staining in normal kidney tissue.
- OI-RD Scanning
Supplier Data
OI-RD Scanning - Anti-CD45 antibody [EP322Y] (AB40763)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
関連する標識済み抗体及び組成の異なる製品 (6)
-
Anti-CD45 antibody [EP322Y] - BSA and Azide free
-
578 PE
PE Anti-CD45 antibody [EP322Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CD45 antibody [EP322Y]
-
660 APC
APC Anti-CD45 antibody [EP322Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CD45 antibody [EP322Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CD45 antibody [EP322Y]
Reactivity data
製品の詳細
Anti-CD45 antibody [EP322Y] (ab40763) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P and WB.
Abcam's high quality manufacturing and validation processes ensure Anti-CD45 antibody [EP322Y] (ab40763) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-CD45 antibody [EP322Y] (ab40763) has 13 independent reviews from customers.
Anti-CD45 antibody [EP322Y] (ab40763) specifically detects CD45 (UniProt ID: P08575; Molecular weight: 145kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).
Conjugation-ready, carrier free format available for antibody clone EP322Y - ab214437.
Antibody clone EP322Y is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, PE, PerCP, APC, Alexa Fluor® 594 (ab200315, ab200317, ab214501, ab220298, ab221245, ab303598).
CD45 regulates immune cell signaling and is crucial in the development and function of immune cells, with alterations linked to various immunodeficiencies and autoimmune diseases.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD45 acts by regulating tyrosine phosphorylation in the immune cell signaling context participating directly in signal transduction. It functions by dephosphorylating specific phosphotyrosine residues on various proteins modulating the signaling threshold required for lymphocyte activation. Although not known to be part of a protein complex CD45 itself shows isoform variation that associates with specific immune cell types impacting their function. Importantly CD45 interacts with multiple signaling molecules to affect cell growth and differentiation.
Pathways
Scientists associate CD45 with signaling pathways such as the T-cell receptor (TCR) and B-cell receptor (BCR) signaling. CD45 modulates the activity of Src family kinases important elements in these pathways making it essential for effective immune response and tolerance. Furthermore interactions between CD45 and proteins like Lck in T-cells or Lyn in B-cells highlight its pivotal role in executing its signaling functions.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (110)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in oncology 15:1632245 PubMed40772038
2025
Applications
Unspecified application
Species
Unspecified reactive species
Physiological reports 13:e70494 PubMed40746221
2025
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 16:1419 PubMed40720004
2025
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 133:756-770 PubMed40646287
2025
Applications
Unspecified application
Species
Unspecified reactive species
Translational oncology 56:102381 PubMed40199156
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation research 18:4551-4565 PubMed40191096
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 25:593 PubMed40169956
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 11:eadr4588 PubMed40153501
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:2974 PubMed40140646
2025
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 15:e70175 PubMed39934971
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com